Short Interest in Senestech, Inc. (NASDAQ:SNES) Grows By 289.5%

by · The Cerbat Gem

Senestech, Inc. (NASDAQ:SNESGet Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 92,345 shares, a growth of 289.5% from the April 30th total of 23,711 shares. Based on an average daily volume of 214,274 shares, the short-interest ratio is currently 0.4 days. Approximately 1.8% of the shares of the company are sold short.

Senestech Trading Down 0.8%

Shares of Senestech stock traded down $0.02 on Friday, reaching $1.78. The company had a trading volume of 14,298 shares, compared to its average volume of 65,685. The firm has a market cap of $9.41 million, a price-to-earnings ratio of -0.94 and a beta of 0.18. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. The firm’s 50-day moving average price is $1.66 and its two-hundred day moving average price is $2.08. Senestech has a 1 year low of $1.41 and a 1 year high of $6.24.

Senestech (NASDAQ:SNESGet Free Report) last released its earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.02. The firm had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.63 million. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%. As a group, research analysts predict that Senestech will post -1.57 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Senestech presently has a consensus rating of “Hold”.

Check Out Our Latest Report on SNES

Insider Transactions at Senestech

In related news, major shareholder Glenbrook Capital Management acquired 15,000 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was bought at an average cost of $1.72 per share, for a total transaction of $25,800.00. Following the purchase, the insider owned 908,635 shares in the company, valued at $1,562,852.20. The trade was a 1.68% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders bought a total of 209,154 shares of company stock worth $392,773 over the last three months. Insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. XTX Topco Ltd purchased a new position in shares of Senestech during the fourth quarter valued at $54,000. DRW Securities LLC raised its holdings in shares of Senestech by 171.1% in the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after acquiring an additional 51,818 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the period. Millennium Management LLC purchased a new stake in Senestech in the third quarter worth about $126,000. Finally, Jane Street Group LLC bought a new position in Senestech during the 2nd quarter worth about $161,000. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Senestech Company Profile

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.

Read More